Spotlight

Dr Celia Caulcott

UCL launches £50 million technology investment fund

UCL is today launching the UCL Technology Fund to invest £50 million in commercialising its world-leading research emerging over the next five years.

Find out more




follow us on twitter


Archive of News

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>

14 September 2012: UCLB signs exclusive global license with Oxford Pharmascience for colonic delivery of statins

UCLB  has entered into an exclusive licence agreement with Oxford Pharmascience Group PLC to develop and commercialise reformulation of statin molecules using the proprietary colon delivery technology (PhloralTM) developed by researchers at UCL School of Pharmacy. More...

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>